Interlace Medical Shareholders Sue Hologic, Inc.

Published: Nov 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shareholders of Interlace Medical, which Hologic acquired in 2011, sue the women's health company for additional payouts of almost $15 million. Hologic (NSDQ:HOLX) has already been through its fair share of legal action from its acquisition of Interlace Medical, which it acquired for $125 million in 2011. Bedford, Mass.-based Hologic lost a patent infringement lawsuit to rival Smith & Nephew (FTSE:SN, NYSE:SNN) last year over the MyoSure fibroid device it bought along with Interlace.

Help employers find you! Check out all the jobs and post your resume.

Back to news